Biomedical Engineering Reference
In-Depth Information
TABLE 11.2. (Continued )
Substrate a
Drug Resistance b
K m ( μ M)
Refs.
Refs.
Chenodeoxycholylglycine
( + GSH) d
5.9
123
Chenodeoxycholyltaurine
( + GSH) d
3.6
123
Ursodeoxycholylglycine
( + GSH) d
12.5
123
Ursodeoxycholyltaurine
( + GSH) d
7.8
123
ADP
118
ABCC5
cGMP e
55
Cadmium chloride
54
cAMP e
55
Potassium antimonyl
54
5-Fluoro-2 -deoxyuridine
monophosphate
1100
127
6-Mercaptopurine
56
5-Fluorouridine
monophosphate
127
6-Thioguanine
56,127
2 -Deoxyuridine
monophosphate
127
PMEA e
56
Folate
1000
128
5-Fluorouracil
127
Methotrexate
1300
128
Methotrexate
127,128
Diglutamylated
methotrexate
700
128
ABCC6
BQ-123
57,58
Etoposide
57
Leukotriene C 4
0.6
57,58
Teniposide
57
S -Glutathionyl
N -ethylmaleimide
282
58
S -Glutathionyl
2,4-dinitrobenzene
57
ABCC10
17 β -Glucuronosyl
estradiol
58
129
Docetaxel
130
Leukotriene C 4
129
Paclitaxel
130
Vincristine
130
Vinblastine
130
ABCC11
5-Fluoro-2 -deoxyuridine
monophosphate
131
5-Fluorouracil
131
Dehydroepiandrosterone
3-sulfate
13
60,132
5-Fluoro-2 -deoxyuridine
131
Estrone 3-sulfate
> 150
60,132
5-Fluoro-5 -deoxyuridine
131
Leukotriene C 4
132
2 ,3 -Dideoxycytidine
131
( Continued )
 
Search WWH ::




Custom Search